The value of in vitro studies in a case of neonatal diabetes with a novel Kir6.2-W68G mutation

In infants, especially with novel previously undescribed mutations of the K(ATP) channel causing neonatal diabetes, in vitro studies can be used to both predict the response to sulphonylurea treatment and support a second trial of glibenclamide at higher than standard doses if the expected response...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Connell, Susan M, Proks, Peter, Kramer, Holger, Mattis, Katia K, Sachse, Gregor, Joyce, Caroline, Houghton, Jayne A L, Ellard, Sian, Hattersley, Andrew T, Ashcroft, Frances M, O'Riordan, Stephen M P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614663/
https://www.ncbi.nlm.nih.gov/pubmed/26509030
http://dx.doi.org/10.1002/ccr3.370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614663/
https://www.ncbi.nlm.nih.gov/pubmed/26509030
http://dx.doi.org/10.1002/ccr3.370

Ejemplares similares